Work / Illustration / CD200 Expression
CD200 is a surface-cell marker that is purported to play a role in activating immune suppression. Understanding these pathways may provide insight into potential targets for the treatment of certain cancers.
John Lapolla, Asante Communications, LLC
XVIVO is in a unique class of crackerjack design companies with honest, capable, supremely talented artists, graphic designers, strategists, and project managers, all of whom are committed to excellence in animation. They understand the unique power of this still evolving art form, its ability to distill otherwise unapproachable biochemical data, and to make it available to the untrained marketing professional, all the while preserving the integrity of the science for the experts who have committed their life’s work to drug discovery and development. Ain’t it easy when you know how to do it?